Microvascular Research is a prominent journal dedicated to advancing the understanding of microvascular biology and its implications in various health and disease contexts. Published by Academic Press Inc elsevier Science, this journal holds a significant place in the academic community with an impact factor reflecting its high citation frequency and relevance within its fields. With a Q2 ranking in both Biochemistry and Cardiology and Cardiovascular Medicine, as well as a Q3 ranking in Cell Biology, it provides an essential platform for researchers and professionals to publish and access groundbreaking studies. Established in 1968 and running through to 2025, Microvascular Research covers a broad scope, focusing on various topics related to microvessels and their functions, emphasizing the importance of these structures in health and pathology. Although the journal does not offer open access, it remains a vital resource for those seeking to deepen their understanding of microvascular dynamics, making it an essential addition to the libraries of researchers, clinicians, and students alike.

The Journal of Vascular Nursing is a premier publication dedicated to advancing the field of vascular nursing, addressing critical issues related to the management and treatment of vascular conditions. Published by Elsevier Science Inc, this esteemed journal boasts an ISSN of 1062-0303 and an E-ISSN of 1532-6578. With a notable impact factor and ranked in the top 39% of journals within the Medical and Surgical Nursing category (Q1), it provides a vital platform for the dissemination of innovative research, clinical practice updates, and evidence-based approaches. Since its inception in 1990, the journal has continued to evolve, offering its readership insights that bridge theory and practice, which are crucial for and beneficial to both seasoned professionals and those entering the field. The Journal of Vascular Nursing is invaluable for anyone invested in enhancing patient outcomes and nursing practices within the realm of vascular health.

Annals of Vascular Diseases is a leading international journal dedicated to the comprehensive exploration of vascular pathology, aimed at advancing knowledge in the field through innovative research and insightful reviews. Published by the ANNALS VASCULAR DISEASES EDITORIAL OFFICE and available in both print (ISSN: 1881-641X) and electronic format (E-ISSN: 1881-6428), this journal has embraced Open Access since 2017, facilitating wider dissemination and accessibility of vital research findings. With its focus on clinical and experimental studies relating to vascular diseases, the journal serves as a crucial platform for researchers, medical professionals, and students who seek to stay at the forefront of clinical advancements. By fostering collaboration and sharing knowledge, Annals of Vascular Diseases plays a significant role in shaping the future of vascular research and treatment strategies worldwide.

Acta Angiologica, published by VIA MEDICA, is an Open Access journal dedicated to the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1995, this esteemed journal has provided a vital platform for the dissemination of cutting-edge research and innovative medical practices, especially pertinent to vascular health. Being indexed in Scopus, it holds a rank of #352 out of 387 in its category for 2023, positioning it in the 9th percentile among contemporaneous journals. The journal's commitment to scholarly excellence and accessibility is underscored by its embrace of open access publishing, allowing researchers, professionals, and students to engage with vital advancements in the field without financial barriers. With a converged timeline from 2005 to 2024, Acta Angiologica continues to play a crucial role in bridging gaps in cardiovascular knowledge, fostering collaboration across disciplines, and advancing the implementation of preventative and therapeutic strategies in vascular medicine. Located in Gdansk, Poland, the journal is poised to make significant contributions to the cardiovascular research landscape.

Vascular Health and Risk Management is a leading peer-reviewed journal published by DOVE MEDICAL PRESS LTD, focusing on the critical areas of cardiology, endocrinology, and public health. With an impact factor that reflects its significance within the scientific community, this Open Access journal, established in 2005, has been committed to enhancing knowledge on the interplay between vascular health and various risk factors affecting patient outcomes. The journal is proudly based in New Zealand and is indexed across multiple categories, maintaining a prominent Q2 ranking in cardiology, endocrinology, diabetes, and several other medical disciplines as of 2023. By providing a platform for innovative research and comprehensive reviews, Vascular Health and Risk Management seeks to foster collaboration among healthcare professionals, enhance clinical practices, and ultimately improve patient care through rigorous scientific inquiry and disseminated knowledge. Researchers, professionals, and students will find invaluable insights that inform their work and advance the understanding of vascular-related health issues.

Vascular is a premier academic journal published by SAGE Publications Ltd, focusing on a wide range of disciplines within the fields of cardiology, cardiovascular medicine, surgery, and radiology. Established in 1993 and continuing through 2024, this journal serves as an essential resource for researchers and professionals seeking to advance their understanding of vascular health and disease. With an impressive categorization in the Q3 quartile for cardiology and cardiovascular medicine, and Q2 quartile for surgery, Vascular has established itself as a reputable platform for disseminating cutting-edge research and innovative clinical practices. The journal's positioning in various Scopus Ranks reflects its relevance and contribution to advancing these critical medical fields, making it an indispensable tool for students, clinicians, and researchers alike. For those interested in keeping abreast of the latest developments, Vascular offers a rich repository of articles that contribute significantly to the global discourse on vascular diseases.

BIORHEOLOGY is a peer-reviewed journal published by IOS PRESS, dedicated to the interdisciplinary field of biorheology, which studies the flow properties of biological fluids and the mechanical behavior of biological tissues. With its ISSN 0006-355X and e-ISSN 1878-5034, this journal has been a vital source of scientific knowledge since its inception in 1965, with coverage extending to recent years and into 2024. As a respected publication within the realms of physiology and biochemistry, it is classified in Q4 in both Physiology and Medical Physiology categories as of 2023, showcasing its niche position within the academic community. The journal primarily aims to disseminate research findings that advance our understanding of biorheological principles and their applications in medicine and biology. Although not listed as open access, BIORHEOLOGY provides essential insights to researchers, professionals, and students eager to explore the complexities of fluid mechanics in biological systems, making it a valuable resource for fostering innovation and collaboration across scientific disciplines.

ANNALS OF VASCULAR SURGERY is a premier journal published by Elsevier Science Inc, focusing on the rapidly evolving field of vascular surgery and its related disciplines. With a notable impact factor reflected in its 2023 Q2 rankings in Cardiology and Cardiovascular Medicine, as well as in Medicine and Surgery, this journal stands out as a reputable source for cutting-edge research and clinical practices. Since its inception in 1986, it has aimed to advance knowledge, foster innovation, and enhance surgical techniques through comprehensive reviews, original research articles, and clinical trials. Although not currently adopting an open access model, the journal continues to serve as a crucial repository of information for researchers, clinicians, and students, facilitating the dissemination of clinical and scientific advancements in vascular health. As it converges through the years towards 2024, the ANNALS OF VASCULAR SURGERY is poised to remain a valuable resource for the global medical community.

Vascular and Endovascular Surgery is a distinguished peer-reviewed journal dedicated to the advancements and innovations in the field of vascular and endovascular medicine. Published by SAGE Publications Inc, this journal serves as a vital platform for clinicians, researchers, and students keen to explore cutting-edge practices, surgical techniques, and emerging therapies within cardiovascular medicine. With an ISSN of 1538-5744 and an E-ISSN of 1938-9116, it has established a solid reputation since its inception, covering articles from its founding years in 1967 to its continuous releases up to 2024. The journal currently holds a Q3 quartile ranking in the categories of Cardiology and Cardiovascular Medicine and Surgery, highlighting its significance within the academic community. Although it is not an open-access journal, it offers valuable content that supports evidence-based practice and clinical decisions in vascular and endovascular procedures. By embracing multidisciplinary collaboration and fostering innovation, Vascular and Endovascular Surgery remains a critical resource for those invested in enhancing patient outcomes and advancing surgical methodologies.

Current Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.